Effects of Time from Diagnosis to Treatment and Baseline Vision on Retinal Vein Occlusion Outcomes in Aflibercept 2 mg Phase III Trials.

Sharma S, Dhoot DS, Grewal DS, Jung E, Silva FQ, Du W, Moini H, Boyer DS

Open source

DOI
10.1016/j.oret.2026.04.027
Published
2026 Sep
Container
Ophthalmology. Retina
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.oret.2026.04.027,
  title = {Effects of Time from Diagnosis to Treatment and Baseline Vision on Retinal Vein Occlusion Outcomes in Aflibercept 2 mg Phase III Trials.},
  author = {Sharma S and Dhoot DS and Grewal DS and Jung E and Silva FQ and Du W and Moini H and Boyer DS},
  year = {2026},
  journal = {Ophthalmology. Retina},
  doi = {10.1016/j.oret.2026.04.027},
  url = {https://doi.org/10.1016/j.oret.2026.04.027}
}

RIS

TY  - JOUR
TI  - Effects of Time from Diagnosis to Treatment and Baseline Vision on Retinal Vein Occlusion Outcomes in Aflibercept 2 mg Phase III Trials.
AU  - Sharma S
AU  - Dhoot DS
AU  - Grewal DS
AU  - Jung E
AU  - Silva FQ
AU  - Du W
AU  - Moini H
AU  - Boyer DS
PY  - 2026
JO  - Ophthalmology. Retina
DO  - 10.1016/j.oret.2026.04.027
UR  - https://doi.org/10.1016/j.oret.2026.04.027
ER  - 

APA

S, S., DS, D., DS, G., E, J., FQ, S., W, D., H, M., & DS, B. (2026). Effects of Time from Diagnosis to Treatment and Baseline Vision on Retinal Vein Occlusion Outcomes in Aflibercept 2 mg Phase III Trials.. Ophthalmology. Retina. https://doi.org/10.1016/j.oret.2026.04.027

Source records